Shigekazu Nagata

Shigekazu Nagata

orcid

Research Focus & Metrics

Academic Career Length

51Years (1976-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2018 in Cell Death & Differentiation
Verified
Journal Article
Open access
Lorenzo GalluzziLorenzo Galluzzi
Lorenzo Galluzzi
IVIlio Vitale
Ilio Vitale
SAStuart A. Aaronson
Stuart A. Aaronson
JAJohn M. Abrams
John M. Abrams
DADieter Adam
Dieter Adam
Guido KroemerGuido Kroemer
Guido Kroemer
Over the past decade, the Nomenclature Committee on Cell Death (NCCD) has formulated guidelines for the definition and interpretation of cell death from morphological, biochemical, and functional perspectives. Since the field continues to expand and novel mechanisms that orchestrate multiple cell death pathways are unveiled, we propose an updated classification of cell death subroutines focusing on mechanistic and essential (as opposed to correlative and dispensable) aspects of the process. As we provide molecularly oriented definitions of terms including intrinsic apoptosis, extrinsic apoptosis, mitochondrial permeability transition (MPT)-driven necrosis, necroptosis, ferroptosis, pyroptosis, parthanatos, entotic cell death, NETotic cell death, lysosome-dependent cell death, autophagy-dependent cell death, immunogenic cell death, cellular senescence, and mitotic catastrophe, we discuss the utility of neologisms that refer to highly specialized instances of these processes. The mission of the NCCD is to provide a widely accepted nomenclature on cell death in support of the continued development of the field.

1 February 1997 in Cell
Verified
Journal Article
Closed access
SNShigekazu Nagata
Shigekazu Nagata

10 March 1995 in Science
Verified
Journal Article
Closed access
PDF file
SNShigekazu Nagata
Shigekazu Nagata
PGPierre Golstein
Pierre Golstein
Fas ligand (FasL), a cell surface molecule belonging to the tumor necrosis factor family, binds to its receptor Fas, thus inducing apoptosis of Fas-bearing cells. Various cells express Fas, whereas FasL is expressed predominantly in activated T cells. In the immune system, Fas and FasL are involved in down-regulation of immune reactions as well as in T cell-mediated cytotoxicity. Malfunction of the Fas system causes lymphoproliferative disorders and accelerates autoimmune diseases, whereas its exacerbation may cause tissue destruction.

1 January 1998 in Nature
Verified
Journal Article
Closed access
PDF file
MEMasato Enari
Masato Enari
HSHideki Sakahira
Hideki Sakahira
HYHideki Yokoyama
Hideki Yokoyama
KOKatsuya Okawa
Katsuya Okawa
AIAkihiro Iwamatsu
Akihiro Iwamatsu
SNShigekazu Nagata
Shigekazu Nagata

1 March 1992 in Nature
Verified
Journal Article
Closed access
PDF file
RWRie Watanabe-Fukunaga
Rie Watanabe-Fukunaga
CBCamilynn I. Brannan
Camilynn I. Brannan
NCNeal G. Copeland
Neal G. Copeland
NJNancy A. Jenkins
Nancy A. Jenkins
SNShigekazu Nagata
Shigekazu Nagata

1 July 1991 in Cell
Verified
Journal Article
Closed access
NINaoto Itoh
Naoto Itoh
SYShin Yonehara
Shin Yonehara
AIAi Ishii
Ai Ishii
MYMinako Yonehara
Minako Yonehara
SMSei-Ichi Mizushima
Sei-Ichi Mizushima
SNShigekazu Nagata
Shigekazu Nagata